The European Medicines Agency ‘Transparency’ Policies, the CJEU and COVID-19: Do the CFREU Provisions Retain Any Relevance?

  • Nasiya Daminova

Research output: Working paper

51 Downloads (Pure)
Original languageEnglish
PublisherTársadalomtudományi Kutatóközpont
Number of pages30
Publication statusPublished - 2021
Externally publishedYes
Publication typeD4 Published development or research report or study

Publication series

NameMTA Law Working Papers
No.2021/1
ISSN (Electronic)2064-4515

Cite this